Primary Site >> Biliary tract Cancer

Gene >> SNAI2

  • 2010
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
Ref: Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma.
PMID: 20503457
Ref: The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma.
PMID: 20594328
 Ref: miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells.
PMID: 24280681
 Ref: EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
PMID: 24704591
Ref: Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.
PMID: 24816558
Ref: Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
PMID: 25471741
 Ref: FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.
PMID: 25749036
Ref: Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
PMID: 26292259
 Ref: A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer.
PMID: 26726879
Ref: Knockdown of RHOC by shRNA suppresses invasion and migration of cholangiocellular carcinoma cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal transition.
PMID: 27108649
 Ref: Blocking ERK1/2 signaling impairs TGF-beta1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cells.
PMID: 28959141